Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised CARGO Therapeutics, Inc. on the offering, and Cooley advised the underwriters. CARGO Therapeutics, Inc. (CARGO) (Nasdaq:CRGX)...
CARGO Therapeutics’ $281.3 Million Initial Public Offering
Jiangsu Hengrui Pharmaceuticals’ License Agreement With Elevar Therapeutics
Cooley advised Jiangsu Hengrui Pharmaceuticals on the deal. Jiangsu Hengrui Pharmaceuticals (“Hengrui”), a global pharmaceutical company focused on scientific and technological innovation, signed a global license agreement...
Jiangsu Hengrui Pharmaceuticals’ License Agreement With Merck
Cooley advised Jiangsu Hengrui Pharmaceuticals on the deal. Jiangsu Hengrui Pharmaceuticals (“Hengrui”), a global pharmaceutical company focused on scientific and technological innovation, announced its strategic collaboration...
ALX Oncology’s $63 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised ALX Oncology Holdings Inc. on the offering, and Cooley advised the underwriters. ALX Oncology Holdings Inc. (Nasdaq:ALXO) announced the pricing...
Roivant Sciences’ $200 Million Common Shares Offering
Davis Polk & Wardwell and Conyers Dill & Pearman advised Roivant Sciences Ltd. on the offering. Cooley advised Immunovant on the transaction. Roivant Sciences Ltd. (Nasdaq:ROIV)...
Trane Technologies’ Acquisition of Nuvolo
Skadden, Arps, Slate, Meagher & Flom LLP served as legal advisor to Trane Technologies, while Cooley LLP served as legal advisor to Nuvolo on the deal....
Wuhan YZY Biopharma’s HK$176 Million Initial Public Offering
Cooley, Jingtian & Gongcheng and King & Wood Mallesons advised YZY Biopharma, while Sidley and Merits & Tree acted as legal counsel for the sole sponsor...
Neumora Therapeutics’ $250.1 Million Initial Public Offering
Latham & Watkins advised Neumora, and Cooley advised the underwriters. Neumora Therapeutics, Inc. announced the pricing of its initial public offering of 14,710,000 shares of its common...
In re Sequenom Inc. Stockholder Litigation
Cooley represented the former board of directors of Sequenom in a nearly seven-year-long securities class action brought by former investors in the company. In July 2016,...
Sierra Ventures’ $265 Million Fund XIII Formation
Cooley advised Sierra Ventures on the fundraising. Sierra Ventures announced its $265 million Fund XIII – which is approximately 20% larger than its previous fund. Proceeds...
Battery Ventures’ Acquisition of GrammaTech’s Software Products
Cooley advised Battery Ventures on the deal. GrammaTech announced that Battery Ventures has acquired its software products division, including the CodeSonar and CodeSentry product lines. The...
Tenable’s $265 Million Acquisition of Ermetic
Cooley advised Tenable on the deal. Tenable Holdings, Inc. (Nasdaq: TENB) announced that it has signed a definitive agreement to acquire Ermetic Ltd. for a purchase...